pharmacological strategy
[대역어] None
[용어속성] Term
[용어속성] Term
Alamandine: Potential Protective Effects in SARS-CoV-2 Patients
알라만딘: SARS-CoV-2 환자의 잠재적인 보호 효과
Review
[키워드] ACE2
acute respiratory distress
acute respiratory syndrome
acute respiratory syndrome coronavirus
acute respiratory syndrome coronavirus 2
alleviate
angiotensin
Angiotensin-converting enzyme
angiotensin-converting enzyme 2
Anti-inflammatory
anti-inflammatory properties
antithrombogenic
benefit
Cardiomyopathy
Characteristics
coronavirus
coronavirus disease
Coronavirus disease 2019
COVID-19
COVID-19 pathogenesis
Effect
fibrosis
G protein-coupled receptor
Health
health benefits
Hospitalization
host cell
host cells
increase
inhibit
interstitial
leads
mortality rates
occur
outcome
pathway
pharmacological strategy
physiological response
Potential
Prevent
proinflammatory
Protective
pulmonary fibrosis
RAS
receptor
reduce
Renin
renin-angiotensin system
respiratory
respiratory distress
SARS-CoV-2
SARS-COV-2 infection
SARS-CoV-2 patient
severe acute respiratory syndrome Coronavirus
severity
Shock
susceptibility
systemic inflammatory
thought
Treatment
upregulation
[DOI] 10.1155/2021/6824259 PMC 바로가기 [Article Type] Review
[DOI] 10.1155/2021/6824259 PMC 바로가기 [Article Type] Review
Differential plasmacytoid dendritic cell phenotype and type I Interferon response in asymptomatic and severe COVID-19 infection
차등 혈장 세포질 수지상 세포 표현형 및 무증상 및 심한 COVID-19 감염에서 I 형 인터페론 반응
Research Article
[키워드] absence
accompanied
adaptive immune responses
Anti-viral
anti-viral IFN
anti-viral response
antiviral responses
Asymptomatic
asymptomatic SARS-CoV-2 infected subjects
Cell
cells
cellular
characterized
chemokine
chemokines
circulating
contribute
coronavirus disease
Coronavirus disease 2019
COVID-19
COVID-19 pathogenesis
COVID-19 patient
Critically ill
Critically ill patient
critically ill patients
cytokine
Cytokine storm
Cytokines
death
Defense
dendritic cell
dendritic cells
disease severity
early phase
elevated
ENhance
epithelial cells
event
Evidence
Ex vivo
expression
fine-tune
Frequency
hospitalized patient
hospitalized patients
Host
host defense
Host-directed therapies
host-directed therapy
human peripheral blood mononuclear cell
IFN
IFN-stimulated gene
Immune cell
immune cells
immune responses
Immunity
IMPROVE
in vitro
induce
Infection
Inflammatory cytokine
Inflammatory cytokines
inflammatory phenotype
inhibiting viral replication
Innate
innate immune response
Innate immunity
Interaction
interferon
interferons
investigated
low frequency
Lung epithelial cells
mechanism
mononuclear cell
multi-organ failure
neuropilin
observation
Pathogenesis
PBMC
PD-L1 marker
pDC/type I IFN axis
Peripheral blood
pharmacological strategy
phenotype
plasmacytoid dendritic cell
plasmacytoid dendritic cells
pro-inflammatory cytokine
pro-inflammatory cytokines
producing
productive viral replication
progression
protective role
regulate
Regulation
released
responsible
resulting
SARS-CoV-2
SARS-CoV-2 infected subject
SARS-COV-2 infection
SARS-CoV-2 pandemic
secreted
secretion
serum
severe COVID-19
Severe COVID-19 Infection
severe COVID-19 patients
stratified
the cytokine storm
the interferon
tissue damage
TLR7/8
type I
type I and III IFNs
type I and III interferons
Type I IFN
type I IFN producing cells
Viral
viral replication
Viral resistance
virus
viruses
[DOI] 10.1371/journal.ppat.1009878 PMC 바로가기 [Article Type] Research Article
[DOI] 10.1371/journal.ppat.1009878 PMC 바로가기 [Article Type] Research Article
Therapeutic Targeting of the Complement System: From Rare Diseases to Pandemics
보완 시스템의 치료적 표적화: 희귀 질병에서 유행병까지
Article
[키워드] activate
approved
Atypical
candidate
chronic disease
Clinical treatment
clinical trials
common disease
complement
contribute
COVID-19
COVID-19 disease
death
Defense
disease
disease pathogenesis
Diseases
disorders
dysfunction
dysregulated
Evidence
example
Hemostasis
homeostasis
Host
include
Inflammation
innate immune system
invading pathogens
ischemia-reperfusion injury
killing
microbes
modulation
molecular pattern
multifunctional
Myocardial infarction
neurologic
organ
Organ failure
pandemic coronavirus
paroxysmal nocturnal hemoglobinuria
pathogen-associated molecular patterns
patient group
pharmacological strategy
pharmacological treatment
plasma
PROTECT
rare disease
robust
Sepsis
severe coronavirus disease
stroke
syndrome
systemic inflammatory
targeting
the antibody
Therapies
therapy
Thromboinflammation
tissue damage
tissue regeneration
tissue repair
trauma
treat
treated
Treatment
[DOI] 10.1124/pharmrev.120.000072 PMC 바로가기 [Article Type] Article
[DOI] 10.1124/pharmrev.120.000072 PMC 바로가기 [Article Type] Article
HIF-1, the Warburg Effect, and Macrophage/Microglia Polarization Potential Role in COVID-19 Pathogenesis
HIF-1, Warburg 효과 및 COVID-19 병인에서 대식세포/미크로글리아 분극의 잠재적 역할
Review
[키워드] Activation
acute respiratory syndrome
acute respiratory syndrome coronavirus
acute respiratory syndrome coronavirus-2
cancers
cause
cellular
Consumption
coronavirus disease
Coronavirus disease 2019
Coronavirus-2
COVID-19
Deterioration
discrepancy
dysfunction
Effect
expression
heterogeneous
HIF-1
hypoxia
hypoxic
immune reaction
IMPROVE
increase in
independent
independent of
Infection
innate immune response
International
knowledge
molecular
Multiorgan
Pathogenesis
pharmacological strategies
pharmacological strategy
polarization
Potential
Prognosis
progression
proinflammatory
role
SARS-CoV-2
Scientific community
Severe acute respiratory syndrome
severe acute respiratory syndrome Coronavirus
solid cancers
suggested
tissue
tissues
Tumor
upregulated
Viral load
[DOI] 10.1155/2021/8841911 PMC 바로가기 [Article Type] Review
[DOI] 10.1155/2021/8841911 PMC 바로가기 [Article Type] Review
Neuronal and Cerebrovascular Complications in Coronavirus Disease 2019
Pharmacology
[키워드] acute respiratory syndrome
affected
aggravate
angiotensin-converting enzyme 2
axonal transport
Brain
cellular component
cerebrovascular
Complication
complications of COVID-19
consequence
Coronavirus disease 2019
Coronavirus-2
COVID-19
COVID-19 patients
Critical
disease
Dizziness
Effect
Evidence
headache
help
highlight
host cell
indicate
Infection
knowledge
loss of taste
mechanism
neurodegeneration
Neurological complication
neuronal
neurons
observation
Occurrence
Other
other organs
Pain
pandemic disease
pathobiology of COVID-19
pharmacological strategy
pharmacological target
problem
problems
respiratory tract
resulting
SARS-CoV-2
SARS-COV-2 infection
SARS-CoV-2 protein
severe acute respiratory syndrome coronavirus-2
stroke
suggested
target
the disease
[DOI] 10.3389/fphar.2020.570031 PMC 바로가기 [Article Type] Pharmacology
[DOI] 10.3389/fphar.2020.570031 PMC 바로가기 [Article Type] Pharmacology
SARS-CoV-2 virus infection: Targets and antiviral pharmacological strategies
SARS-CoV-2 바이러스 감염: 표적 및 항바이러스 약리학적 전략
Article
[키워드] Abstract
Antiviral
antiviral drugs
COVID-19
pharmacological strategy
SARS-CoV-2
SARS-CoV-2 virus
target
therapeutic targets
therapeutic targets.
[DOI] 10.1111/jebm.12414 PMC 바로가기 [Article Type] Article
[DOI] 10.1111/jebm.12414 PMC 바로가기 [Article Type] Article